Imunon Inc (IMNN) concluded trading on Thursday at a closing price of $0.79, with 0.47 million shares of worth about $0.37 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.23% during that period and on July 03, 2025 the price saw a loss of about -1.24%. Currently the company’s common shares owned by public are about 20.32M shares, out of which, 17.74M shares are available for trading.
Stock saw a price change of -1.06% in past 5 days and over the past one month there was a price change of -58.63%. Year-to-date (YTD), IMNN shares are showing a performance of -37.29% which decreased to -16.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.37 but also hit the highest price of $3.65 during that period. The average intraday trading volume for Imunon Inc shares is 11.29 million. The stock is currently trading -28.71% below its 20-day simple moving average (SMA20), while that difference is down -26.52% for SMA50 and it goes to -17.16% lower than SMA200.
Imunon Inc (NASDAQ: IMNN) currently have 20.32M outstanding shares and institutions hold larger chunk of about 7.84% of that.
The stock has a current market capitalization of $16.05M and its 3Y-monthly beta is at 2.19. It has posted earnings per share of -$1.41 in the same period. It has Quick Ratio of 0.88 while making debt-to-equity ratio of 2.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IMNN, volatility over the week remained 10.70% while standing at 14.57% over the month.
Analysts are in expectations that Imunon Inc (IMNN) stock would likely to be making an EPS of -0.33 in the current quarter, while forecast for next quarter EPS is -0.2 and it is -0.61 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.56 which is -0.23 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.51 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 42.44% while it is estimated to increase by 54.60% in next year. EPS is likely to grow at an annualized rate of 37.97% for next 5-years, compared to annual growth of 32.54% made by the stock over the past 5-years.
